Acorda Therapeutics Accounts Payables 2011-2026 | ACOR

Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.

Main types of accounts payable

Type of liability	Example
To suppliers and contractors	Goods received but not yet paid for
Taxes and fees	VAT, income tax, etc., not paid on time
Salaries	Employee wages not paid
To budgets	Insurance contributions to funds not paid
To founders	Founders provided borrowed funds
To banks	Overdue loan payments
Other	Fines, penalties, forfeits, customer prepayments, etc.

Impact on the company's financial performance

Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios
Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence
Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals)
Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated

Annual Accounts Payables Acorda Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
13.4 M	9.81 M	10.8 M	12.2 M	26.3 M	48.9 M	27.4 M	26.9 M	14.2 M	17.8 M	15.9 M	22.5 M	21.4 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
48.9 M	9.81 M	20.6 M

Quarterly Accounts Payables Acorda Therapeutics

2024-Q1	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
9.93 M	2.85 M	9.81 M	11.5 M	7.96 M	8.77 M	10.8 M	15.5 M	17.5 M	9.49 M	12.2 M	12.2 M	12.2 M	12.2 M	26.3 M	26.3 M	26.3 M	26.3 M	48.9 M	48.9 M	48.9 M	48.9 M	27.4 M	27.4 M	27.4 M	27.4 M	26.9 M	26.9 M	26.9 M	26.9 M	14.2 M	14.2 M	14.2 M	14.2 M	17.8 M	17.8 M	17.8 M	17.8 M	15.9 M	15.9 M	15.9 M	15.9 M	22.5 M	22.5 M	22.5 M	22.5 M	21.4 M	21.4 M	21.4 M	21.4 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
48.9 M	2.85 M	20.8 M

Accounts Payables of other stocks in the Biotechnology industry

Issuer	Accounts Payables	Price	% 24h	Market Cap	Country
Alector ALEC	1.69 M	$ 2.11	-13.17 %	$ 217 M	USA
Acer Therapeutics ACER	3.81 M	-	2.71 %	$ 14 M	USA
Axsome Therapeutics AXSM	65.5 M	$ 163.89	-	$ 8.15 B	USA
BridgeBio Pharma BBIO	36.2 M	$ 64.28	-3.31 %	$ 12.3 B	USA
I-Mab IMAB	570 M	-	-	$ 866 M	China
BioCardia BCDA	890 K	$ 1.37	5.81 %	$ 29 M	USA
AgeX Therapeutics AGE	1.41 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	677 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	2.91 M	-	-	$ 26.5 M	USA
BioMarin Pharmaceutical BMRN	32.8 M	$ 59.8	-3.13 %	$ 11.5 B	USA
Bristol-Myers Squibb Company BMY	3.58 B	$ 62.08	-0.46 %	$ 126 B	USA
Benitec Biopharma BNTC	201 K	$ 10.93	0.23 %	$ 450 M	USA
Black Diamond Therapeutics BDTX	4.01 M	$ 2.38	-3.44 %	$ 131 M	USA
ARCA biopharma ABIO	3.46 M	-	1052.0 %	$ 415 M	USA
BioXcel Therapeutics BTAI	16 M	$ 1.63	-2.4 %	$ 4.13 M	USA
Acasti Pharma ACST	601 K	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	1.61 M	-	-	$ 86.2 M	USA
Akero Therapeutics AKRO	9.03 M	-	-	$ 3.67 B	USA
Akouos AKUS	1.28 M	-	0.23 %	$ 488 M	USA
BeyondSpring BYSI	295 K	$ 1.34	-0.87 %	$ 54 M	USA
Albireo Pharma ALBO	6.52 M	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	1.03 M	-	3.16 %	$ 1.9 M	USA
Cabaletta Bio CABA	4.55 M	$ 3.34	0.61 %	$ 3.9 M	USA
Aileron Therapeutics ALRN	911 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	247 K	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	561 K	$ 4.88	2.74 %	$ 10.6 B	Israel
Alpine Immune Sciences ALPN	4.29 M	-	-	$ 2.17 B	USA
Capricor Therapeutics CAPR	183 K	$ 27.28	-2.32 %	$ 731 M	USA
Ampio Pharmaceuticals AMPE	750 K	-	-11.43 %	$ 502 K	USA
Catalyst Biosciences CBIO	355 K	$ 11.67	-3.47 %	$ 768 M	USA
Applied Molecular Transport AMTI	1.58 M	-	-	$ 10.1 M	USA
Aravive ARAV	8.76 M	-	-13.39 %	$ 1.45 M	USA
C4 Therapeutics CCCC	858 K	$ 3.06	13.3 %	$ 254 M	USA
Aptose Biosciences APTO	1.26 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	724 K	-	-39.0 %	$ 4.57 M	USA
Athira Pharma ATHA	319 K	-	-	$ 269 M	USA
Codexis CDXS	2.84 M	$ 0.99	-2.04 %	$ 72.7 M	USA
Aridis Pharmaceuticals ARDS	2.31 M	-	17.91 %	$ 11.1 M	USA